- ASSOCIATE PROFESSOR Neurology
- ASSOCIATE PROFESSOR Ophthalmology
Janet C. Rucker, MD is Associate Professor in the Departments of Neurology and Ophthalmology at the Mount Sinai School of Medicine in New York. Prior to that, she was Associate Professor in the Departments of Neurology and Ophthalmology at Rush University in Chicago. She received her undergraduate degree from Drury University, Springfield, MO, where she graduated Summa Cum Laude, and her MD from St. Louis University. She completed an internship in Internal Medicine, a residency in Neurology, and a fellowship in Neuro-Ophthalmology at Emory University in Atlanta. She is board certified in Neurology. Dr. Rucker joined Mount Sinai School of Medicine in February 2009.
Dr. Rucker's area of clinical practice, research, and academic teaching is Neuro-Ophthalmology. She is a member of the American Academy of Neurology, where she serves as an executive member of the Neuro-Ophthalmology/Neuro-Otology subsection. She is an active member serving on several committees in the North American Neuro-Ophthalmology Society, the primary international subspecialty society of Neuro-Ophthalmology. In addition to extensive teaching at the annual meetings of the above societies, Dr. Rucker teaches at the American Academy of Ophthalmology and frequently lectures as a visiting professor. She is on the editorial board of the primary Neuro-Ophthalmology peer-reviewed journal, the Journal of Neuro-Ophthalmology, and is Neuro-Ophthalmology section editor for the British Journal of Ophthalmology. In addition, she is an abstract editor for the journal Neuro-Ophthalmology, and for the online medical literature review Faculty of 1000 Medicine.
Her primary research interest is application of quantitative extraocular movement recordings to clinical practice, to advance the understanding of neural connections governing normal and abnormal eye movements. Particular diseases of research interest in eye movements include movement disorders such as Parkinson's disease and Progressive Supranuclear Palsy and demyelinating disorders such as multiple sclerosis. Dr. Rucker has authored or co-authored numerous peer-reviewed publications and nearly 30 review articles and book chapters. Her areas of clinical expertise include eye movement abnormalities due to brain, cranial nerve, neuromuscular junction, or extraocular muscle pathology; optic nerve and intracranial visual pathway disorders such as optic nerve tumors, optic neuritis, ischemic optic neuropathies, and idiopathic intracranial hypertension; and disorders of the pupil.
In the NewsDr. Rucker discusses intracranial hypertension in The Daily News feature The Daily Check Up.
ResearchDr. Rucker performs quantitative eye movement recordings in patients with abnormal eye movements to help with diagnosis of neurological conditions and to improve understanding of normal brain function.
Wilker SC, Rucker JC, Newman NJ, Biousse V, Tomsak RL. Pain in ischemic ocular motor cranial nerve palsies. Br J Ophthalmol 2009;: in press.
Rucker JC. Neuro-ophthalmology of systemic disease. Semin Neurol 2009; 29: 111-123.
Gupta PK, Bhatti MT, Rucker JC. A sweet case of bilateral sixth nerve palsies. Surv Ophthalmol 2009; 54: 305-310.
Rucker JC. Lee A, Brazis P, Kline L, Chang D, editors. Nystagmus treatments. In: Curbside Consultation - Neuro-Ophthalmology (2009). Slack Incorporated;.
Optican LM, Rucker JC, Keller EL, Leigh RJ. Mechanisms of interrupted saccades in patients with late-onset Tay Sachs. Prog Brain Res 2008; 171: 567-570.
Rucker JC, Leigh RJ, Optican LM, Keller EL, Buettner-Ennever JA. Ocular motor anatomy in a case of interrupted saccades. Prog Brain Res 2008; 171: 563-566.
Rucker JC. Nystagmus treatment. Semin Ophthalmol 2008; 23: 91-97.
Buracchio T, Rucker JC. Pearls and oysters of localization in ophthalmoparesis. Neurology 2007; 69: E35-E40.
Rucker JC. Ocular motility in multiple sclerosis. Int Neuro-ophthalmol 2007; 47: 1-13.
Rucker JC. Bradley WG, Daroff RB, Fenichel G, Jankovic J, editors. Cranial nerves. In: Bradley and Daroff Neurology in Clinical Practice, 5th ed. (2007). Butterworth-Heinemann;.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Rucker did not report having any of the following types of financial relationships with industry during 2013 and/or 2014: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
17 East 102 Street Floor 8th
New York, NY 10029